Listed on GrantGunner. Last checked 3 Oct 2026.
About this grant
A credit-linked incentive scheme for existing small and medium pharma companies to upgrade manufacturing units to meet Revised Schedule-M and WHO-GMP standards. Eligible units can receive an incentive of 10% to 20% of their investment, up to a maximum of ₹2 crore, based on average turnover over the last three years.
Who can apply
Pharmaceutical manufacturing units with a turnover of less than ₹500 crore, with preference for MSMEs.